Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 79, 2019 - Issue 6
Submit an article Journal homepage
1,382
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Transthyretin Glu54Leu – an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type

Urban HellmanDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; View further author information
,
Kenneth LångDepartment of Medicine, Piteå Hospital, Piteå, Sweden; View further author information
,
Elisabet IhseDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; View further author information
,
Jenni JonassonClinical Genetics, Laboratory Medicine, Department of Medical Bioscience/Medical and Clinical Genetics, Umeå University, Umeå, Sweden; View further author information
,
Malin OlssonDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; ;Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, SwedenView further author information
,
Hans-Erik LundgrenDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; View further author information
,
Björn PilebroDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; View further author information
,
Per WestermarkDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; View further author information
,
Jonas WixnerDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; View further author information
&
Intissar AnanDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; ;Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, SwedenCorrespondence[email protected]
View further author information
 show all
Pages 372-376 | Received 26 Mar 2019, Accepted 25 May 2019, Published online: 06 Jun 2019

References

  • Lai Z, Colon W, Kelly JW. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry. 1996;35:6470–6482.
  • Quintas A, Vaz DC, Cardoso I, et al. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem. 2001;276:27207–27213.
  • Bergstrom J, Gustavsson A, Hellman U, et al. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol. 2005;206:224–232.
  • Ihse E, Rapezzi C, Merlini G, et al. Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. Amyloid. 2013;20:142–150.
  • Ihse E, Ybo A, Suhr O, et al. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol. 2008;216:253–261.
  • Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve. 2007;36:411–423.
  • Nuvolone M, Obici L, Merlini G. Transthyretin-associated familial amyloid polyneuropathy-current and emerging therapies. Eur Neurol Rev. 2012;7:14–21.
  • Rowczenio DM, Noor I, Gillmore JD, et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat. 2014;35:E2403–E2412.
  • Pilebro B, Suhr OB, Naslund U, et al. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis. Ups J Med Sci. 2016;121:17–24.
  • Quarta CC, Gonzalez-Lopez E, Gilbertson JA, et al. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis. Eur Heart J. 2017;38:1905–1908.
  • Bergstrom J, Murphy CL, Weiss DT, et al. Two different types of amyloid deposits-apolipoprotein A-IV and transthyretin-in a patient with systemic amyloidosis. Lab Invest. 2004;84:981–988.
  • Rapezzi C, Quarta CC, Guidalotti PL, et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging. 2011;4:659–670.
  • Goldsteins G, Andersson K, Olofsson A, et al. Characterization of two highly amyloidogenic mutants of transthyretin. Biochemistry. 1997;36:5346–5352.
  • Yamamoto K, Hsu SP, Yoshida K, et al. Familial amyloid polyneuropathy in Taiwan: identification of transthyretin variant (Leu55->Pro). Muscle Nerve. 1994;17:637–641.
  • Togashi S, Watanabe H, Nagasaka T, et al. An aggressive familial amyloidotic polyneuropathy caused by a new variant transthyretin Lys 54. Neurology. 1999;53:637–639.
  • Busse A, Sanchez MA, Monterroso V, et al. A severe form of amyloidotic polyneuropathy in a Costa Rican family with a rare transthyretin mutation (Glu54Lys). Am J Med Genet A. 2004;128A:190–194.
  • Kim HS, Kim SM, Kang SW, et al. An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene. Eur J Neurol. 2005;12:657–659.
  • Wojtczak A, Cody V, Luft JR, et al. Structures of human transthyretin complexed with thyroxine at 2.0 A resolution and 3',5'-dinitro-N-acetyl-L-thyronine at 2.2 A resolution. Acta Crystallogr D Biol Crystallogr. 1996;52:758–765.
  • Klabunde T, Petrassi HM, Oza VB, et al. Rational design of potent human transthyretin amyloid disease inhibitors. Nat Struct Biol. 2000;7:312–321.
  • Miyata M, Sato T, Mizuguchi M, et al. Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding. Biochemistry. 2010;49:114–123.
  • Yokoyama T, Mizuguchi M, Nabeshima Y, et al. Hydrogen-bond network and pH sensitivity in transthyretin: neutron crystal structure of human transthyretin. J Struct Biol. 2012;177:283–290.
  • Sebastiao MP, Saraiva MJ, Damas AM. The crystal structure of amyloidogenic Leu55 –> Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J Biol Chem. 1998;273:24715–24722.
  • Liepnieks JJ, Wilson DL, Benson MD. Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis. Amyloid. 2006;13:170–177.
  • Gustavsson A, Jahr H, Tobiassen R, et al. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest. 1995;73:703–708.
  • Westermark P, Sletten K, Johansson B, et al. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA. 1990;87:2843–2845.
  • Marcoux J, Mangione PP, Porcari R, et al. A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis. EMBO Mol Med. 2015;7:1337–1349.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.